Episode 97. Photobiomodulation Devices and Research (including Long COVID)
Mar 19, 2024
auto_awesome
A deep dive into photobiomodulation devices and research, including their potential benefits for long COVID patients. Discussions on therapeutic effects of near infrared light on oxidative stress and blood clots, mechanisms of cellular functions, inflammation reduction, and pain relief. Exploring pulsed waves in therapy for improved sleep and cognitive function, with insights on device designs and ongoing clinical trials.
Photobiomodulation devices show promise in treating long COVID through hormone and immune system modulation.
Mitochondrial dysfunction in long COVID can be addressed by photobiomodulation therapy using near-infrared light to support mitochondrial function and reduce oxidative stress.
Deep dives
Photobiomodulation Therapy and Its Health Benefits
Photobiomodulation, utilizing light in health, is an expanding field. Devices for brain photobiomodulation have shown promise, potentially impacting conditions like long COVID. This therapy involves diverse effects such as hormone modulation, immune system modulation, and antimicrobial effects. Research in this area has been exponentially growing, revealing the numerous benefits of light therapy on the human body.
Mitochondrial Dysfunction in Long COVID and the Role of Light Therapy
Mitochondrial dysfunction has emerged as a major factor in long COVID development. Studies link COVID-19 to increased oxidative stress and mitochondrial damage. Photobiomodulation's ability to penetrate deep into tissues, especially near-infrared light, can aid in mitigating reactive oxygen species and supporting mitochondrial function. Sunlight exposure and specific light wavelengths have demonstrated potential in reducing oxidative stress in COVID patients.
Practical Implementation of Photobiomodulation and Research Advances
The application of light therapy, including devices like helmets emitting specific wavelengths, shows promising results in various conditions like Alzheimer's, brain injuries, and depression. Research databases categorizing thousands of studies underscore the growing interest and evidence supporting the efficacy of photobiomodulation. Although FDA approval for specific devices is pending, ongoing trials and advancements aim to standardize and optimize light therapy protocols for improved health outcomes.
Roger Seheult, MD of MedCram examines photobiomodulation devices and research, including long COVID. See all Dr. Seheult's videos at: https://www.medcram.com/
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.
MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:
MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.